GovChime
Notice ID: 01a109ef5743ab9a0595be921ac532d6Special Notice

99--Test efficaciousness of a number of potential stoichiometric and catalytic enzymes as pretreatments against the toxcity of chemical warfare nerve agents in vivo in animal models.

Archived on August 21, 2012. Full description on SAM.gov.

Overview

Posted
May 23, 2012
Notice type
Special Notice
NAICS
541711: Classification Not Available

Notice details

PSC
99: MISCELLANEOUS
Last updated
Dec 4, 2025

Identifiers

Solicitation number
W81XWH12T0264
Notice ID
01a109ef5743ab9a0595be921ac532d6

Description

The US Army Medical Research Acquisition Activity (USAMRAA) has a procurement requirement for the US Army Medical Research Institute of Chemical Defense (USAMRICD) at Aberdeen Proving Grounds, MD 21010. The strategy is to award a firm-fixed-price contract over a 36 month time frame consisting of six 6-month ordering periods; a base period and 5 optional periods. The authority cited is Federal Acquisition Regulation (FAR) 13.106-1(b). This is a follow-on requirement for commercially available purified recombinant adenoviruses directly related to previous work completed by Welgen Incorporated, 100 Barber Avenue, Worcester MA. The follow-on protocol requires the same work and results for contunity of on-going research and for the research to contiune without break in performance. To award to a new vendor could jeopardize the protocol by receiving different results due to process differences. A solicitation SF 1449 will not be provided. If any companies can meet the Government's above need, a capabilities statement can be sent to Erin Maddox at erin.maddox@amedd.army.mil. This serves as the Government's intent to award a sole source to ensure the research mission at USAMRICD is not comprimised. If no responses are received by 8:00 am eastern standard time on 5 June 2012, the strategy will commence.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Erin Jessica Maddox, 410-417-0028 US Army Medical Research Acquisition Activity

Documents

No documents available.

Lifecycle

Solicitation:W81XWH12T0264
  1. Special NoticeCurrentMay 23, 2012

    99--Test efficaciousness of a number of potential stoichiometric and catalytic enzymes as pretreatments against the toxcity of chemical warfare nerve agents in vivo in animal models.

    Notice 01a109ef5743ab9a0595be921ac532d6 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

W81XWH12T0264

Archive Date

Aug 21, 2012